Dr. Hussain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16777 Medical Center Dr
Baton Rouge, LA 70816Phone+1 225-761-5200Fax+1 225-754-5053
Summary
- Dr. Nazneen Hussain is a gastroenterologist based in Baton Rouge, LA. She completed her fellowship in Gastroenterology and residency in Internal Medicine at Louisiana State University School of Medicine, completing her studies in 2019. Her published research includes work on liver cholestasis, anorectal melanoma, and Crohn's disease, with several articles cited multiple times in other publications. Dr. Hussain was awarded the Presidential Poster Award from the American College of Gastroenterology in 2017.
Education & Training
Louisiana State University School of MedicineFellowship, Gastroenterology, 2016 - 2019- Louisiana State University School of MedicineResidency, Internal Medicine, 2013 - 2016
LSU School of Medicine in ShreveportClass of 2013
Certifications & Licensure
LA State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Presidential Poster Award American College of Gastroenterology, 2017
Publications & Presentations
PubMed
- 7 citationsLiver Cholestasis Secondary to Syphilis in an Immunocompetent PatientNazneen Hussain, Samuel Igbinedion, Richie Diaz, Jonathan Steven Alexander, Moheb Boktor
Case Reports in Hepatology. 2018-10-22 - 1 citationsGastrointestinal Bleeding Secondary to Portal Hypertensive Duodenopathy in a Patient with Decompensated Liver CirrhosisRohini Krishna, Samuel Igbinedion, Richie Diaz, Nazneen Hussain, Moheb Boktor
Case Reports in Gastrointestinal Medicine. 2018-10-18 - 6 citationsSubstitution with Alternative Anti-TNFα Therapy (SAVANT)-Outcomes of a Crohn's Disease Cohort Undergoing Substitution Therapy with Certolizumab.Moheb Boktor, Andrew Motlis, Avinash Aravantagi, Ankur Sheth, Paul Jordan
Inflammatory Bowel Diseases. 2016-06-01
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
